HighVista Strategies’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,993
| Closed | -$693K | – | 142 |
|
|
2023
Q2 | $693K | Sell |
7,993
-1,708
| -18% | -$148K | 0.32% | 90 |
|
|
2023
Q1 | $943K | Hold |
9,701
| – | – | 0.77% | 38 |
|
|
2022
Q4 | $1M | Sell |
9,701
-120
| -1% | -$12.4K | 0.6% | 43 |
|
|
2022
Q3 | $833K | Buy |
9,821
+1,225
| +14% | +$104K | 0.48% | 51 |
|
|
2022
Q2 | $712K | Buy |
8,596
+3,003
| +54% | +$249K | 0.43% | 55 |
|
|
2022
Q1 | $431K | Buy |
+5,593
| New | +$431K | 0.27% | 79 |
|
|
2020
Q3 | – | Sell |
-3,384
| Closed | -$417K | – | 119 |
|
|
2020
Q2 | $417K | Buy |
+3,384
| New | +$417K | 0.35% | 53 |
|